In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients.

Wanja Kassuhn,Pedro R Cutillas,Mirjana Kessler,Jalid Sehouli,Elena I Braicu,Nils Blüthgen,Hagen Kulbe

Cancers（2023）

引用 0|浏览2

暂无评分

摘要

By utilizing a sophisticated bioinformatics approach, several candidates for treatment opportunities, including YAP1 and NR2F6 were identified. These candidates represent signalling regulators within the cellular network of the MES. Hence, further studies to confirm these candidates as potential targeted therapies in PM are warranted.

查看译文

关键词

ovarian cancer,yap1,subtype-specific

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要